PDL BioPharma reports Q3 results (NASDAQ:PDLI)
PDL BioPharma (NASDAQ:PDLI): Q3 GAAP EPS of -$0.64. Revenue of $7.1M (-12.3% Y|Y) Press Release
PDL BioPharma reports Q3 results (NASDAQ:PDLI)
PDL BioPharma (NASDAQ:PDLI): Q3 GAAP EPS of -$0.64. Revenue of $7.1M (-12.3% Y|Y) Press Release